News
AstraZeneca (LSE:AZN) received EU approval for its cancer treatment Imfinzi, marking a significant product-related milestone.
Every bladder cancer journey is different, and no single treatment or diagnostic path fits everyone. According to patients who have experienced bladder cancer, the best care for you will depend on ...
UK MHRA approves Serum Life Science Europe’s Anktiva to treat adult patients with non-muscle invasive bladder cancer: United Kingdom Monday, July 7, 2025, 12:00 Hrs [IST] The UK ...
A fundraiser has been set up to help a Sanibel resident and member of the island and business community with her husband’s ...
Declines in ESA hyporesponsiveness are significantly associated with increased malignancy risk in patients with CKD not on dialysis.
NetworkNewsWire Editorial Coverage NEW YORK, July 7, 2025 /CNW/ -- An estimated 20 million people are diagnosed annually with ...
An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year worldwide ( ) with these numbers expected to grow. The American Cancer Society ...
NetworkNewsWire Editorial Coverage NEW YORK, July 7, 2025 /PRNewswire/ -- An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people ...
The marathon runner believed it was just common teenage problems that were plaguing her daughter, not a tumour ...
The athlete admitted the red flags were “pretty easily dismissed” as ordinary teenage issues rather than cancer symptoms ...
This Bollywood movie made ₹27 crore of business in 1989, which is equivalent to approximately ₹291 crore today. It was made ...
Prostate cancer is one of the most common cancers in men, but when caught early, it's highly treatable. For Vernon Owens, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results